PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8(+) T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Tumor-reactive T cell exhaustion prevents the success of immune therapies. Pegilodecakin activates intratumoral CD8(+) T cells in mice and induces objective tumor responses in patients. Here we report that pegilodecakin induces hallmarks of CD8(+) T cell immunity in cancer patients, including elevat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell
Main Authors: Naing, Aung, Infante, Jeffrey R., Papadopoulos, Kyriakos P., Chan, Ivan H., Shen, Cong, Ratti, Navneet P., Rojo, Bianca, Autio, Karen A., Wong, Deborah J., Patel, Manish R., Ott, Patrick A., Falchook, Gerald S., Pant, Shubham, Hung, Annie, Pekarek, Kara L., Wu, Victoria, Adamow, Matthew, McCauley, Scott, Mumm, John B., Wong, Phillip, Vlasselaer, Peter Van, Leveque, Joseph, Tannir, Nizar M., Oft, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8098754/
https://ncbi.nlm.nih.gov/pubmed/30423297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2018.10.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados